Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1953 2
1954 1
1957 1
1958 6
1959 5
1960 2
1961 1
1962 3
1963 1
1964 1
1965 1
1967 4
1969 3
1970 3
1971 1
1972 4
1973 4
1974 2
1975 2
1976 5
1977 3
1978 4
1979 3
1980 5
1982 2
1983 4
1984 1
1985 2
1986 2
1989 2
1997 1
1999 2
2001 2
2002 1
2003 3
2004 3
2005 1
2006 1
2007 1
2008 1
2009 1
2010 3
2011 3
2012 6
2013 4
2014 2
2015 3
2016 3
2017 3
2018 8
2019 8
2020 7
2021 7
2022 9
2023 3
2024 4
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

170 results

Results by year

Filters applied: . Clear all
Page 1
Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis.
Ytterberg SR, Bhatt DL, Mikuls TR, Koch GG, Fleischmann R, Rivas JL, Germino R, Menon S, Sun Y, Wang C, Shapiro AB, Kanik KS, Connell CA; ORAL Surveillance Investigators. Ytterberg SR, et al. N Engl J Med. 2022 Jan 27;386(4):316-326. doi: 10.1056/NEJMoa2109927. N Engl J Med. 2022. PMID: 35081280 Clinical Trial.
AGA Clinical Practice Guidelines on the Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohn's Disease.
Feuerstein JD, Ho EY, Shmidt E, Singh H, Falck-Ytter Y, Sultan S, Terdiman JP; American Gastroenterological Association Institute Clinical Guidelines Committee. Feuerstein JD, et al. Among authors: shmidt e. Gastroenterology. 2021 Jun;160(7):2496-2508. doi: 10.1053/j.gastro.2021.04.022. Gastroenterology. 2021. PMID: 34051983 Free PMC article. No abstract available.
Reply.
Shmidt E, Faleck DM, Colombel JF. Shmidt E, et al. Clin Gastroenterol Hepatol. 2022 Feb;20(2):469. doi: 10.1016/j.cgh.2021.04.010. Epub 2021 Apr 8. Clin Gastroenterol Hepatol. 2022. PMID: 33839279 No abstract available.
Development and Validation of a Scoring System to Predict Outcomes of Vedolizumab Treatment in Patients With Crohn's Disease.
Dulai PS, Boland BS, Singh S, Chaudrey K, Koliani-Pace JL, Kochhar G, Parikh MP, Shmidt E, Hartke J, Chilukuri P, Meserve J, Whitehead D, Hirten R, Winters AC, Katta LG, Peerani F, Narula N, Sultan K, Swaminath A, Bohm M, Lukin D, Hudesman D, Chang JT, Rivera-Nieves J, Jairath V, Zou GY, Feagan BG, Shen B, Siegel CA, Loftus EV Jr, Kane S, Sands BE, Colombel JF, Sandborn WJ, Lasch K, Cao C. Dulai PS, et al. Among authors: shmidt e. Gastroenterology. 2018 Sep;155(3):687-695.e10. doi: 10.1053/j.gastro.2018.05.039. Epub 2018 May 30. Gastroenterology. 2018. PMID: 29857091 Free PMC article.
Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial.
van der Heijde D, Cheng-Chung Wei J, Dougados M, Mease P, Deodhar A, Maksymowych WP, Van den Bosch F, Sieper J, Tomita T, Landewé R, Zhao F, Krishnan E, Adams DH, Pangallo B, Carlier H; COAST-V study group. van der Heijde D, et al. Lancet. 2018 Dec 8;392(10163):2441-2451. doi: 10.1016/S0140-6736(18)31946-9. Epub 2018 Oct 22. Lancet. 2018. PMID: 30360964 Clinical Trial.
Dermatologic infestations.
Shmidt E, Levitt J. Shmidt E, et al. Int J Dermatol. 2012 Feb;51(2):131-41. doi: 10.1111/j.1365-4632.2011.05191.x. Int J Dermatol. 2012. PMID: 22250620 Review.
Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes.
Marso SP, McGuire DK, Zinman B, Poulter NR, Emerson SS, Pieber TR, Pratley RE, Haahr PM, Lange M, Brown-Frandsen K, Moses A, Skibsted S, Kvist K, Buse JB; DEVOTE Study Group. Marso SP, et al. N Engl J Med. 2017 Aug 24;377(8):723-732. doi: 10.1056/NEJMoa1615692. Epub 2017 Jun 12. N Engl J Med. 2017. PMID: 28605603 Free PMC article. Clinical Trial.
Response to Andrew et al.
Gottlieb ZS, Dolinger MT, Shmidt E, Dubinsky MC. Gottlieb ZS, et al. Among authors: shmidt e. Am J Gastroenterol. 2023 Nov 1;118(11):2097-2098. doi: 10.14309/ajg.0000000000002465. Am J Gastroenterol. 2023. PMID: 37916755 No abstract available.
Inflammatory Bowel Disease and Pregnancy.
Shmidt E, Dubinsky MC. Shmidt E, et al. Am J Gastroenterol. 2022 Oct 1;117(10S):60-68. doi: 10.14309/ajg.0000000000001963. Am J Gastroenterol. 2022. PMID: 36194035 No abstract available.
Development and Validation of Clinical Scoring Tool to Predict Outcomes of Treatment With Vedolizumab in Patients With Ulcerative Colitis.
Dulai PS, Singh S, Vande Casteele N, Meserve J, Winters A, Chablaney S, Aniwan S, Shashi P, Kochhar G, Weiss A, Koliani-Pace JL, Gao Y, Boland BS, Chang JT, Faleck D, Hirten R, Ungaro R, Lukin D, Sultan K, Hudesman D, Chang S, Bohm M, Varma S, Fischer M, Shmidt E, Swaminath A, Gupta N, Rosario M, Jairath V, Guizzetti L, Feagan BG, Siegel CA, Shen B, Kane S, Loftus EV Jr, Sandborn WJ, Sands BE, Colombel JF, Lasch K, Cao C. Dulai PS, et al. Among authors: shmidt e. Clin Gastroenterol Hepatol. 2020 Dec;18(13):2952-2961.e8. doi: 10.1016/j.cgh.2020.02.010. Epub 2020 Feb 13. Clin Gastroenterol Hepatol. 2020. PMID: 32062041 Free PMC article.
170 results